These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 13491414)

  • 41. Neuropharmacological reassessment of the discriminative stimulus properties of d-lysergic acid diethylamide (LSD).
    Cunningham KA; Appel JB
    Psychopharmacology (Berl); 1987; 91(1):67-73. PubMed ID: 3103161
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of lysergic acid derivatives and antihistamines as inhibitors of the edema provoked in the rat's paw by serotonin.
    DOEPFNER W; CERLETTI A
    Int Arch Allergy Appl Immunol; 1958; 12(1-2):89-97. PubMed ID: 13549054
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of and interaction between tranquilizers, serotonin and lysergic acid diethylamide on the body temperature of pigeons.
    HOFFMAN RA
    Am J Physiol; 1958 Dec; 195(3):751-4. PubMed ID: 13606253
    [No Abstract]   [Full Text] [Related]  

  • 44. [Lesions of the central nervous system in Carassius auratus caused by serotonin and the protective action of lysergic acid diethylamide].
    BRUSA A; GIANNIOTTI G; SACCHI U
    Boll Soc Ital Biol Sper; 1956 Jun; 32(6):438-41. PubMed ID: 13374116
    [No Abstract]   [Full Text] [Related]  

  • 45. Some CNS electrophysiologic effects of serotonin and lysergic acid diethylamide.
    GUNN CG
    Psychiatr Res Rep Am Psychiatr Assoc; 1960 Jan; 12():194-203. PubMed ID: 13851827
    [No Abstract]   [Full Text] [Related]  

  • 46. Effects of lysergic acid diethylamide on the uptake and retention of brain 5-hydroxytryptamine in vivo and in vitro.
    Ziegler MG; Lovell RA; Freedman DX
    Biochem Pharmacol; 1973 Sep; 22(17):2183-93. PubMed ID: 4270151
    [No Abstract]   [Full Text] [Related]  

  • 47. Reduction of stimulation-produced analgesia by lysergic acid deithylamide, a depressor of serotonergic neural activity.
    Hayes RL; Newlon PG; Rosecrans JA; Mayer DJ
    Brain Res; 1977 Feb; 122(2):367-72. PubMed ID: 837237
    [No Abstract]   [Full Text] [Related]  

  • 48. [Absence of specificity of various histamine and 5-hydroxytryptamine antagonists in rats].
    Lecomte J
    C R Seances Soc Biol Fil; 1966; 160(10):1972-5. PubMed ID: 4383114
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of lysergic acid diethylamide on the metabolism of brain 5-hydroxytryptamine.
    Rosecrans JA; Lovell RA; Freedman DX
    Biochem Pharmacol; 1967 Oct; 16(10):2011-21. PubMed ID: 6065966
    [No Abstract]   [Full Text] [Related]  

  • 50. [Influence of serotonin inhibitors and derivatives of phenylethylamine on serotonin-induced psychomotor depression in mice].
    Fischer E; Saavedra JM; Smolovich J
    C R Seances Soc Biol Fil; 1968; 162(8):1623-4. PubMed ID: 4238204
    [No Abstract]   [Full Text] [Related]  

  • 51. Quantum chemical studies on drug actions. 3. Correlation of hallucinogenic and anti-serotonin activity of lysergic acid derivatives with quantum chemical data.
    Kumbar M; Sankar DV
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):65-100. PubMed ID: 4734018
    [No Abstract]   [Full Text] [Related]  

  • 52. Receptors for sympathomimetic amines and 5-hydroxytryptamine in the rat aorta.
    Krishnamurty VS
    Arch Int Pharmacodyn Ther; 1971 Jan; 189(1):90-9. PubMed ID: 5130156
    [No Abstract]   [Full Text] [Related]  

  • 53. 5-[3H]hydroxytryptamine and [3H]lysergic acid diethylamide binding to human platelets.
    Peters JR; Geaney DP; Grahame-Smith DG
    Methods Enzymol; 1992; 215():201-13. PubMed ID: 1435321
    [No Abstract]   [Full Text] [Related]  

  • 54. Antagonism of d-lysergic acid diethylamide and mescaline by 1-methyl-1, 2, 5, 6-tetrahydropyridine-N, N-diethyl-carboxamide (THPC).
    Dyer DC; Benington F; Morin RD
    Arch Int Pharmacodyn Ther; 1975 Oct; 217(2):197-200. PubMed ID: 127560
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Involvement of brain serotonin in the stimulant action of amphetamine and of cholinolytics.
    Lapin IP; Oxenkrug GF; Azbekyan SG
    Arch Int Pharmacodyn Ther; 1972 Jun; 197(2):350-61. PubMed ID: 4260601
    [No Abstract]   [Full Text] [Related]  

  • 56. Antagonism of beta-phenylethylamine derivatives and serotonin blocking drugs upon serotonin, tryptamine and reserpine behavioral depression in mice.
    Saavedra JM; Fischer E
    Arzneimittelforschung; 1970 Jul; 20(7):952-7. PubMed ID: 5536068
    [No Abstract]   [Full Text] [Related]  

  • 57. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The modification of bulbo-spinal facilitation of the monosynaptic reflex by 5-hydroxytryptamine precursors and antagonists.
    Barasi S; Roberts MH
    J Physiol; 1973 Feb; 229(1):33P-34P. PubMed ID: 4347743
    [No Abstract]   [Full Text] [Related]  

  • 59. [Specific inhibition of serotonin effects by lysergic acid diethylamide and similar compounds].
    CERLETTI A; KONZETT H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1956; 228(1-2):146-8. PubMed ID: 13334586
    [No Abstract]   [Full Text] [Related]  

  • 60. Blockade of depressor responses to serotonin and tryptamine by lysergic acid derivatives in the chicken.
    BUNAG RD; WALASZEK EJ
    Arch Int Pharmacodyn Ther; 1962 Jan; 135():142-51. PubMed ID: 13874645
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.